Furthermore, the removal of the PRC2/EZH2 complex in a mouse model of EZH2-overexpressing breast cancer can inhibit cancer proliferation, supporting the notion that EZH2 may influence cancer proliferation (10). This evidence concerns the gene EZH2 and breast carcinoma.